Literature DB >> 2647863

Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area.

C Ferreccio1, M M Levine, H Rodriguez, R Contreras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2647863     DOI： 10.1093/infdis/159.4.766

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  38 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.

Authors:  J Y Wang; M F Pasetti; F R Noriega; R J Anderson; S S Wasserman; J E Galen; M B Sztein; M M Levine
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains.

Authors:  T I Crean; M John; S B Calderwood; E T Ryan
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 4.  Tracking the dynamics of T-cell activation in response to Salmonella infection.

Authors:  Rajesh Ravindran; Stephen J McSorley
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

5.  Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.

Authors:  Rezwanul Wahid; Rosangela Salerno-Gonçalves; Carol O Tacket; Myron M Levine; Marcelo B Sztein
Journal:  Vaccine       Date:  2006-11-03       Impact factor: 3.641

Review 6.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 7.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

8.  Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

Authors:  K L Kotloff; D A Herrington; T L Hale; J W Newland; L Van De Verg; J P Cogan; P J Snoy; J C Sadoff; S B Formal; M M Levine
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 9.  Advances in vaccines for typhoid fever.

Authors:  A Gupta; S Jalla; S Sazawal; M K Bhan
Journal:  Indian J Pediatr       Date:  1994 Jul-Aug       Impact factor: 1.967

Review 10.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.